Literature DB >> 6618948

Low exercise pulmonary resistance is not dependent on vasodilator prostaglandins.

J Lindenfeld, J T Reeves, L D Horwitz.   

Abstract

In resting conscious dogs, administration of cyclooxygenase inhibitors results in modest increases in pulmonary arterial pressure and pulmonary vascular resistance, suggesting that vasodilator prostaglandins play a role in maintaining the low vascular resistance in the pulmonary bed. To assess the role of these vasodilator prostaglandins on pulmonary vascular resistance during exercise, we studied seven mongrel dogs at rest and during exercise before and after intravenous meclofenamate (5 mg/kg). Following meclofenamate, pulmonary vascular resistance rose both at rest (250 24 vs. 300 +/- 27 dyn . s . cm-5, P less than 0.01) and with exercise (190 +/- 9 vs. 210 +/- 12 dyn . s . cm-5, P less than 0.05). Systemic vascular resistance rose slightly following meclofenamate both at rest and during exercise. There were no changes in cardiac output. The effects of cyclooxygenase inhibition, although significant, were less during exercise than at rest. This suggests that the normal fall in pulmonary vascular resistance during exercise depends largely on factors other than vasodilator prostaglandins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6618948     DOI: 10.1152/jappl.1983.55.2.558

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  3 in total

1.  Nitric oxide blunts the endothelin-mediated pulmonary vasoconstriction in exercising swine.

Authors:  Birgit Houweling; Daphne Merkus; Marjolein M D Dekker; Dirk J Duncker
Journal:  J Physiol       Date:  2005-08-04       Impact factor: 5.182

Review 2.  Pulmonary circulation at exercise.

Authors:  Robert Naeije; N Chesler
Journal:  Compr Physiol       Date:  2012-01       Impact factor: 9.090

3.  Changes in pulmonary vascular tone during exercise. Effects of nitric oxide (NO) synthase inhibition, L-arginine infusion, and NO inhalation.

Authors:  T Koizumi; R Gupta; M Banerjee; J H Newman
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.